Table 1 Patients preoperative and surgical characteristics.

Age, years, mean (SD)

65 (12)

Gender (m:f)

86:78

BMI, kg/m², mean (SD)

25.6 (4.7)

ASA, n (%)

1–2

109 (66)

3–4

55 (34)

Preoperative WHO performance status, n (%)

0

19 (12)

1–3

145 (88)

Active smoker, n (%)

44 (27)

Diabetes, n (%)

28 (17)

Malignant tumor, n (%)

142 (86)

Neoadjuvant chemotherapy, n (%)

11 (7)

Operation length, min, median (IQR),

335 (288–378)

Venous resection, n (%)

37 (22)

Pancreatic texture, n (%)

Soft

80 (49)

Hard

65 (40)

Unknown

19 (11)

Pancreatic main duct, n (%)

Dilated > 2 mm

71 (43)

Non-dilated

85 (52)

Unknown

8 (5)

Intraoperative infusion of vasoactive drugs, n (%)

163 (99)

Fluid administration guidance, n (%)

Pulse pressure variation

114 (69)

Oesophageal doppler

11 (7)

Transoesophageal echocardiography

2 (1)

Unknown

37 (23)

Estimated blood loss, ml, median (IQR),

440 (300–800)